Calmer Brains in Very Preterm Infants

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age26-30
SponsorUniversity of British Columbia

About this trial

Very preterm infants in the neonatal intensive care unit (NICU) need lifesaving medical procedures which can be stressful and affect brain development. Calmer was invented to mimic key parts of parental holding (touch, heartbeat sounds and breathing motion) to help reduce stress if parents cannot be there to hold their infant. Using specialized brain scans done at full term, we will gather initial information in 22 infants born 3-4 months early to compare brain development in infants who receive Calmer at least 3 hours each day (+ regular NICU care) over 2-3 weeks with infants who have regular NICU care.

Eligibility criteria

Qualifiers

Very preterm infants admitted to the NICU at the BC Women's Hospital

Disqualifiers

Congenital anomalies;

Born small for GA (per medical admission history);

History of birthing parent substance use in pregnancy;

Ongoing infection at the time of enrollment;

Trial design

Treatments tested in this trial

  • Calmer

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of British Columbia

Lead sponsor

BC Children's Hospital Research Institute

Collaborator